Valeriana officinalis extract and its main component, valerenic acid, ameliorate d-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation

Experimental Gerontology

Volumn 48, Issue 11, 2013, Pages 1369-1377

  Nam, Sung Min ^a   Choi, Jung Hoon ^b   Yoo, Dae Young ^a   Kim, Woosuk ^a   Jung, Hyo Young ^a   Kim, Jong Whi ^a   Kang, Soo Yong ^c   Park, Jaeil ^c   Kim, Dong Woo ^c   Kim, Wan Jae ^c   Yoon, Yeo Sung ^a   Hwang, In Koo ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

^c Central Research Center   (South Korea)

Author keywords

Aging; Hippocampus; Lipid peroxidation; Neurogenesis; Serum corticosterone; Valerian root extract

Indexed keywords

CORTICOSTERONE; GALACTOSE; LIPID; UNCLASSIFIED DRUG; VALERENIC ACID; VALERIAN;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COGNITION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DENTATE GYRUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MAZE TEST; MEMORY; MOUSE; NEUROBLAST; NONHUMAN; OBJECT RELATION; PATTERN RECOGNITION; PLANT ROOT; PRIORITY JOURNAL; SWIMMING; VALERIANA OFFICINALIS;

AGING; HIPPOCAMPUS; LIPID PEROXIDATION; NEUROGENESIS; SERUM CORTICOSTERONE; VALERIAN ROOT EXTRACT;

AGING; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CORTICOSTERONE; DENTATE GYRUS; GALACTOSE; INDENES; LIPID PEROXIDATION; MALE; MEMORY; MICE; MICE, INBRED C57BL; NEURAL STEM CELLS; NEUROGENESIS; NOOTROPIC AGENTS; PLANT EXTRACTS; PLANTS, MEDICINAL; SESQUITERPENES; VALERIAN;

EID: 84884699091     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2013.09.002     Document Type: Article

References (48)

1. Abrous D.N., Koehl M., Le Moal M. Adult neurogenesis: from precursors to network and physiology. Physiol. Rev. 2005, 85:523-569.
2. Anderson G.D., Elmer G.W., Taibi D.M., Vitiello M.V., Kantor E., Kalhorn T.F., Howald W.N., Barsness S., Landis C.A. Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women. Phytother. Res. 2010, 24:1442-1446.
3. A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology 2009, 56:174-181.
4. Bos R., Woerdenbag H.J., van Putten F.M., Hendriks H., Scheffer J.J. Seasonal variation of the essential oil, valerenic acid and derivatives, and velopotriates in Valeriana officinalis roots and rhizomes, and the selection of plants suitable for phytomedicines. Planta Med. 1998, 64:143-147.
5. Brown J.P., Couillard-Després S., Cooper-Kuhn C.M., Winkler J., Aigner L., Kuhn H.G. Transient expression of doublecortin during adult neurogenesis. J. Comp. Neurol. 2003, 467:1-10.
6. A receptor in rat brain. Arzneimittelforschung 1995, 45:753-755.
7. Chen C.F., Lang S.Y., Zuo P.P., Yang N., Wang X.Q., Xia C. Effects of D-galactose on the expression of hippocampal peripheral-type benzodiazepine receptor and spatial memory performances in rats. Psychoneuroendocrinology 2006, 31:805-811.
8. Couillard-Despres S., Winner B., Schaubeck S., Aigner R., Vroemen M., Weidner N., Bogdahn U., Winkler J., Kuhn H.G., Aigner L. Doublecortin expression levels in adult brain reflect neurogenesis. Eur. J. Neurosci. 2005, 21:1-14.
9. Cui X., Zuo P., Zhang Q., Li X., Hu Y., Long J., Packer L., Liu J. Chronic systemic D-galactose exposure induces memory loss, neurodegeneration, and oxidative damage in mice: protective effects of R-α-lipoic acid. J. Neurosci. Res. 2006, 84:647-654.
10. Das J., Mao A.A., Handique P.J. Terpenoid compositions and antioxidant activities of two Indian valerian oils from the Khasi Hills of north-east India. Nat. Prod. Commun. 2011, 6:129-132.
11. De Oliveria D.M., Barreto G., De Andrade D.V., Saraceno E., Aon-Bertolino L., Capani F., Dos Santos El R., Bachá L.D. Giraldez Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson's disease. Neurochem. Res. 2009, 34:215-220.
12. Ennanceur A., Delacour J. A new one trial-test for neurobiological studies of memory in rats. 1: behavioral data. Behav. Brain Res. 1988, 31:47-59.
13. Fabel K., Kempermann G. Physical activity and the regulation of neurogenesis in the adult and aging brain. Neruomol. Med. 2008, 10:59-66.
14. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego.
15. Ge S., Goh E.L., Sailor K.A., Kitabatake Y., Ming G.L., Song H. GABA regulates synaptic integration of newly generated neurons in the adult brain. Nature 2006, 439:589-593.
16. Hadley S., Petry J.J. Valerian. Am. Fam. Physician 2003, 67:1755-1758.
17. Hallam K.T., Olver J.S., McGrath C., Norman T.R. Comparative cognitive and psychomotor effects of single doses of Valeriana officinalis and triazolam in healthy volunteers. Hum. Psychopharmacol. 2003, 18:619-625.
18. Houghton P.J. The scientific basis for the reputed activity of Valerian. J. Pharm. Pharmacol. 1999, 51:505-512.
19. Jagasia R., Steib K., Englberger E., Herold S., Faus-Kessler T., Saxe M., Gage F.H., Song H., Lie D.C. GABA-cAMP response element-binding protein signaling regulates maturation and survival of newly generated neurons in the adult hippocampus. J. Neurosci. 2009, 29:7966-7977.
20. Kinsner A., Pilotto V., Deininger S., Brown G.C., Coecke S., Hartung T., Bal-Price A. Inflammatory neurodegeneration induced by lipoteichoic acid from Staphylococcus aureus is mediated by glia activation, nitrosative and oxidative stress, and caspase activation. J. Neurochem. 2005, 95:1132-1143.
21. Kuhlmann J., Berger W., Podzuweit H., Schmidt U. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers. Pharmacopsychiatry 1999, 32:235-241.
22. Lazarov O., Mattson M.P., Peterson D.A., Pimplikar S.W., van Praag H. When neurogenesis encounters aging and disease. Trends Neurosci. 2010, 33:569-579.
23. Lee C.H., Yoo D.Y., Park O.K., Park J.H., Yi S.S., Yoon Y.S., Won M.H., Hwang I.K. Effects of adrenalectomy and replacement therapy of corticosterone on cell proliferation and neuroblast differentiation in the rat dentate gyrus. Neurochem. Res. 2011, 36:1767-1775.
24. Lei M., Hua X., Xiao M., Ding J., Han Q., Hu G. Impairments of astrocytes are involved in the D-galactose-induced brain aging. Biochem. Biophys. Res. Commun. 2008, 369:1082-1087.
25. Limoli C.L., Giedzinski E., Baure J., Rola R., Fike J.R. Altered growth and radiosensitivity in neural precursor cells subjected to oxidative stress. Int. J. Radiat. Biol. 2006, 82:640-647.
26. Lu J., Zheng Y.L., Luo L., Wu D.M., Sun D.X., Feng Y.J. Quercetin reverses D-galactose induced neurotoxicity in mouse brain. Behav. Brain Res. 2006, 171:251-260.
27. Malva J.O., Santos S., Macedo T. Neuroprotective properties of Valeriana officinalis extracts. Neurotox. Res. 2004, 6:131-140.
28. Marder M., Viola H., Wasowski C., Fernández S., Medina J.H., Paladini A.C. 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol. Biochem. Behav. 2003, 75:537-545.
29. Mills S., Bone K. Principles and Practice of Phytotherapy 2000, Churchill Livingston, London.
30. Montaron M.F., Piazza P.V., Aurousseau C., Urani A., Le Moal M., Abrous D.N. Implication of corticosteroid receptors in the regulation of hippocampal structural plasticity. Eur. J. Neurosci. 2003, 18:3105-3111.
31. A receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier. Planta Med. 2008, 74:1338-1344.
32. 3H]GABA release. Neurochem. Res. 1999, 24:1373-1378.
33. Pawluski J.L., Brummelte S., Barha C.K., Crozier T.M., Galea L.A. Effects of steroid hormones on neurogenesis in the hippocampus of the adult female rodent during the estrous cycle, pregnancy, lactation and aging. Front. Neuroendocrinol. 2009, 30:343-357.
34. Pereira R.P., Fachinetto R., de Souza Prestes A., Wagner C., Sudati J.H., Boligon A.A., Athayde M.L., Morsch V.M., Rocha J.B. Valeriana officinalis ameliorates vacuous chewing movements induced by reserpine in rats. J. Neural Transm. 2011, 118:1547-1557.
35. Pinnock S.B., Herbert J. Brain-derived neurotropic factor and neurogenesis in the adult rat dentate gyrus: interactions with corticosterone. Eur. J. Neurosci. 2008, 27:2493-2500.
36. Poon H.F., Castegna A., Farr S.A., Thongboonkerd V., Lynn B.C., Banks W.A., Morley J.E., Klein J.B., Butterfield D.A. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 2004, 126:915-926.
37. Sahay A., Scobie K.N., Hill A.S., O'Carroll C.M., Kheirbek M.A., Burghardt N.S., Fenton A.A., Dranovsky A., Hen R. Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature 2011, 472:466-470.
38. Sampath C., Haug K., Thanei S., Hamburger M., Derendorf H., Frye R., Butterweck V. Pharmacokinetics of valerenic acid in rats after intravenous and oral administrations. Planta Med. 2012, 78:575-581.
39. Santos M.S., Ferreira F., Cunha A.P., Carvalho A.P., Ribeiro C.F., Macedo T. Synaptosomal GABA release as influenced by valerian root extract-involvement of the GABA carrier. Arch. Int. Pharmacodyn. Ther. 1994, 327:220-231.
40. Sernagor E., Chabrol F., Bony G., Cancedda L. GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: general rules and differences in diverse systems. Front. Cell. Neurosci. 2010, 4:11.
41. Song X., Bao M., Li D., Li Y.M. Advanced glycation in D-galactose induced mouse aging model. Mech. Ageing Dev. 1999, 108:239-251.
42. Sudati J.H., Fachinetto R., Pereira R.P., Boligon A.A., Athayde M.L., Soares F.A., de Vargas Barbosa N.B., Rocha J.B. In vitro antioxidant activity of Valeriana officinalis against different neurotoxic agents. Neurochem. Res. 2009, 34:1372-1379.
43. Tang J.Y., Zeng Y.S., Chen Q.G., Qin Y.J., Chen S.J., Zhong Z.Q. Effects of Valerian on the level of 5-hydroxytryptamine, cell proliferation and neurons in cerebral hippocampus of rats with depression induced by chronic mild stress. Zhong Xi Yi Jie He Xue Bao 2008, 6:283-288.
44. A receptors by valerian extracts is related to the content of valerenic acid. Planta Med. 2008, 74:19-24.
45. Vitali M., Venturelli E., Galimberti D., Benerini Gatta L., Scarpini E., Finazzi D. Analysis of the genes coding for subunit 10 and 15 of cytochrome c oxidase in Alzheimer's disease. J. Neural Transm. 2009, 116:1635-1641.
46. Wei H., Li L., Song Q., Ai H., Chu J., Li W. Behavioural study of the D-galactose induced aging model in C57BL/6J mice. Behav. Brain Res. 2005, 157:245-251.
47. Yoo D.Y., Kim W., Lee C.H., Shin B.N., Nam S.M., Choi J.H., Won M.H., Yoon Y.S., Hwang I.K. Melatonin improves D-galactose-induced aging effects on behavior, neurogenesis, and lipid peroxidation in the mouse dentate gyrus via increasing pCREB expression. J. Pineal Res. 2012, 52:21-28.
48. Yuan C.S., Mehendale S., Xiao Y., Aung H.H., Xie J.T., Ang-Lee M.K. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth. Analg. 2004, 98:353-358.